We're all set for a new experience. To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open48.75
High48.82
Low48.68
Prev. Close46.5
Avg. Traded Price48.75
Volume4,787

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
000
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

48.6815 hours ago
48.8215 hours ago
arrow

LOWER/UPPER CIRCUITS

44.18
48.82
arrow
Colinz Laboratories Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Net Profit,rose 2.03% in the last year to ₹0.5 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
notePrice to Earning Ratio,is 23.59, lower than its sector PE ratio of 43.7.
noteQuarterly Net profit,rose 10.59% YoY to ₹0.15 Cr. Its sector's average net profit growth YoY for the quarter was 37.63%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 41.97%
Net profit growth 5Y CAGR : 31.84%
Colinz Laboratories Ltd is engaged in the manufacture of Pharmaceutical Formulations (of all dosages forms)like Tablets Capsules Parenterals Creams/ Ointments/Lotions Dry Powder Liquid Orals Soft Gelatine Capsules under the Therapeutic Segments they offer Anti Biotics & Anti Bacterials Anti Hypertensives Diuretics Lipid lowering Agents (Cholestrole Reducers) Anti Emetics etc Vetinary formulations like Feed mix Bolus & Vitamins & Others Nutraceuticals like Spirulina Clucosamine Lecithin etc;Herbal Preparations like Pain Balm &Anti Cold Rub Ayurvedic Skin Care Creams Capsules/Tablets/ Creams/ Powders etc.The company is also engaged in turn key projects from Design erection & commissioning of pharma formulation plants and Transfer of technical know how (Pilot Batch to Commercial productions).
personal

Grow your wealth with more research recommendations

+91